ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,664.10
0.00%
S&P ASX All Technology
3,014.80
0.00%
Brent Oil
85.905
-1.58%
US Dollar vs AUD
1.54295
1.24%
Bitcoin
60,153.07
-5.77%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) News

WGS GeneDx Holdings Corporation

16.78
5.78 (52.55%)
After Hours
Last Updated: 07:03:54
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
GeneDx Holdings Corporation WGS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
5.78 52.55% 16.78 07:03:54
Open Price Low Price High Price Close Price Previous Close
14.28 13.90 18.24 17.07 11.00
more quote information »

Recent News

Date Time Source Heading
30/4/202406:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
23/4/202422:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
05/4/202407:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
14/3/202423:30GLOBEGeneDx to Present Data at the 2024 American College of..
06/3/202408:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202408:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
24/2/202408:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202408:28EDGAR2Form 8-K - Current report
21/2/202408:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
02/2/202408:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
25/1/202408:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
24/1/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:58EDGAR2Form 8-K - Current report
09/1/202400:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
05/1/202409:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202313:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202313:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202308:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202300:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
29/11/202308:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
21/11/202308:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
18/11/202308:15EDGAR2Form SC 13D/A - General statement of acquisition of..
04/11/202307:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202307:33EDGAR2Form 8-K - Current report
31/10/202307:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
24/10/202308:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202307:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
04/10/202307:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202306:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
20/9/202308:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202308:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202308:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202308:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202322:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
07/9/202306:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
21/8/202321:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
09/8/202310:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
09/8/202306:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202306:13EDGAR2Form 8-K - Current report
09/8/202306:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
07/8/202322:00GLOBEPacBio and GeneDx Launch Research Collaboration with the..
28/7/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202307:04EDGAR2Form 8-K - Current report
22/7/202311:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202321:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..

Your Recent History

NASDAQ
WGS
GeneDx
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved